Details for New Drug Application (NDA): 022114
✉ Email this page to a colleague
The generic ingredient in ZINGO is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.
Summary for 022114
Tradename: | ZINGO |
Applicant: | Powder Pharms |
Ingredient: | lidocaine hydrochloride |
Patents: | 3 |
Pharmacology for NDA: 022114
Physiological Effect | Local Anesthesia |
Suppliers and Packaging for NDA: 022114
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ZINGO | lidocaine hydrochloride | SYSTEM;INTRADERMAL | 022114 | NDA | Powder Pharmaceutical Incorporated | 61388-123 | 61388-123-26 | 12 POWDER in 1 POUCH (61388-123-26) |
ZINGO | lidocaine hydrochloride | SYSTEM;INTRADERMAL | 022114 | NDA | Powder Pharmaceutical Incorporated | 61388-123 | 61388-123-48 | 48 CARTON in 1 BOX (61388-123-48) / 12 POWDER in 1 CARTON (61388-123-12) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SYSTEM;INTRADERMAL | Strength | 0.5MG | ||||
Approval Date: | Aug 16, 2007 | TE: | RLD: | No | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Oct 22, 2029 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | ZINGO INTRADERMAL INJECTION SYSTEM IS A DRUG DELIVERY SYSTEM THAT IS CAPABLE OF DELIVERING FINE DRY POWDERED LIDOCAINE HYDROCHLORIDE MONOHYDRATE FOR LOCAL ANESTHETIC ACTION | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Apr 27, 2035 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | ZINGO IS A POWDER INTRADERMAL SYSTEM THAT IS CAPABLE OF DELIVERING FINE DRY POWDERED LIDOCAINE HYDROCHLORIDE MONOHYDRATE FOR LOCAL ANESTHETIC ACTION | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Sep 28, 2035 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | ZINGO IS A POWDER INTRADERMAL SYSTEM THAT IS CAPABLE OF DELIVERING FINE DRY POWDERED LIDOCAINE HYDROCHLORIDE MONOHYDRATE FOR LOCAL ANESTHETIC ACTION |
Expired US Patents for NDA 022114
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Powder Pharms | ZINGO | lidocaine hydrochloride | SYSTEM;INTRADERMAL | 022114-001 | Aug 16, 2007 | ⤷ Sign Up | ⤷ Sign Up |
Powder Pharms | ZINGO | lidocaine hydrochloride | SYSTEM;INTRADERMAL | 022114-001 | Aug 16, 2007 | ⤷ Sign Up | ⤷ Sign Up |
Powder Pharms | ZINGO | lidocaine hydrochloride | SYSTEM;INTRADERMAL | 022114-001 | Aug 16, 2007 | ⤷ Sign Up | ⤷ Sign Up |
Powder Pharms | ZINGO | lidocaine hydrochloride | SYSTEM;INTRADERMAL | 022114-001 | Aug 16, 2007 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription